Literature DB >> 17446537

Partial splenic embolization in the treatment of patients with portal hypertension: a review of the english language literature.

Kristen Gledhill Koconis1, Harjit Singh, Gregory Soares.   

Abstract

This article reviews the existing literature on the use of partial splenic embolization in patients with portal hypertension. All articles published in the English language on splenic embolization or partial splenic embolization as a treatment for portal hypertension were identified with a PubMed search from 1973 through 2005. Partial splenic embolization appears to be efficacious in reducing episodes of variceal bleeding, improving hematologic parameters, enhancing hepatic protein synthesis, and reducing the severity of hepatic encephalopathy. Associated morbidity and mortality appear to be acceptable. The literature, however, is limited in quality. Given the potential benefits of partial splenic embolization, further investigation is warranted to allow evidence-based evaluation of its use.

Entities:  

Mesh:

Year:  2007        PMID: 17446537     DOI: 10.1016/j.jvir.2006.12.734

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  41 in total

1.  Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia.

Authors:  Heba M Abdella; Amal T Abd-El-Moez; Mohammed E Abu El-Maaty; Ali Z Helmy
Journal:  Indian J Gastroenterol       Date:  2010-05-05

2.  Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism.

Authors:  Wei-Dong Gong; Ke Xue; Yuan-Kui Chu; Qing Wang; Wei Yang; Hui Quan; Peng Yang; Zhi-Min Wang; Zhi-Qun Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 3.  Imaging and radiological interventions in extra-hepatic portal vein obstruction.

Authors:  Sudheer S Pargewar; Saloni N Desai; S Rajesh; Vaibhav P Singh; Ankur Arora; Amar Mukund
Journal:  World J Radiol       Date:  2016-06-28

4.  Which Arteries Are Expendable? The Practice and Pitfalls of Embolization throughout the Body.

Authors:  Thomas R Burdick; Eric K Hoffer; Todd Kooy; Basavaraj Ghodke; Benjamin W Starnes; Karim Valji; Steve Goldberg; Danial Hallam; R Torrance Andrews
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

5.  Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option.

Authors:  Guilherme Lopes P Martins; Joao Paulo G Bernardes; Marcello S Rovella; Raphael G Andrade; Publio Cesar C Viana; Paulo Herman; Giovanni Guido Cerri; Marcos Roberto Menezes
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

6.  Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension.

Authors:  Min Shi; Jue Wei; Wen-Ying Meng; Na Wang; Ting Wang; Yu-Gang Wang
Journal:  Exp Ther Med       Date:  2016-06-14       Impact factor: 2.447

7.  Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).

Authors:  Sun Young Choi; Jong Yun Won; Kyung Ah Kim; Do Yun Lee; Kwang-Hun Lee
Journal:  Eur Radiol       Date:  2010-08-26       Impact factor: 5.315

8.  Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder.

Authors:  Robert Gianotti; Hearns Charles; Kenneth Hymes; Hersh Chandarana; Samuel Sigal
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

9.  Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.

Authors:  Jin-Hua Huang; Fei Gao; Yang-Kui Gu; Wen-Quan Li; Lian-Wei Lu
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

10.  Interventional radiology in the management of portal hypertension.

Authors:  Sundeep J Punamiya
Journal:  Indian J Radiol Imaging       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.